KRAS Mutant Non-Small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch KRAS Mutant Non-Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors (NCT02022982) | Dana-Farber Cancer Institute | 2014-01-01 |
Track KRAS Mutant Non-Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.